Cathepsin cysteine protease inhibitors

Details for Australian Patent Application No. 2004266740 (hide)

Owner Merck Frosst Canada Ltd.

Inventors Truong, Vouy Linh; Gauthier, Jacques Yves

Agent Spruson & Ferguson

Pub. Number AU-B-2004266740

PCT Pub. Number WO2005/019161

Priority 60/496,825 21.08.03 US

Filing date 19 August 2004

Wipo publication date 3 March 2005

Acceptance publication date 26 August 2010

International Classifications

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

C07C 255/46 (2006.01) Carboxylic acid nitriles

C07C 317/32 (2006.01) Sulfones

C07D 277/30 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

9 March 2006 PCT application entered the National Phase

  PCT publication WO2005/019161 Priority application(s): WO2005/019161

26 August 2010 Application Accepted

  Published as AU-B-2004266740

23 December 2010 Standard Patent Sealed

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004266741-Childproof micronutrient supplement

2004266737-Multi-axial orthopedic device and system, e.g. for spinal surgery